ProCure and Seattle Cancer Care Alliance to Offer Advanced Cancer Therapy
SEATTLE--(BUSINESS WIRE)-- ProCure Treatment Centers, Inc. (ProCure) and Seattle Cancer Care Alliance (SCCA) announced today that they have closed financing and funded capital for the proton therapy center they are building in Seattle. Site preparation work is under way in anticipation of a spring groundbreaking ceremony. Patients are expected to begin treatment in 2013.
The Seattle facility is the second ProCure center to close financing in the past 12 months and will become the fourth in its network of proton therapy centers that includes Oklahoma City (opened 2009), suburban Chicago (opened 2010) and Somerset, N.J., which serves the metro New York area (opening 2012). ProCure is the only healthcare company in the world that has developed and is operating multiple proton centers.
“We are excited to have closed financing and be one step closer to providing this important cancer treatment to more patients,” said Hadley Ford, CEO of ProCure. “We look forward to continuing our relationship with SCCA and achieving a milestone toward both our missions as we bring this advanced treatment to the Pacific Northwest.”
SCCA, along with its partner institutions – Fred Hutchinson Cancer Research Center, University of Washington Medicine and Seattle Children’s – is the only National Cancer Institute-designated comprehensive cancer center in the Pacific Northwest. SCCA is dedicated to excellence in cancer research, education and patient treatment. Bringing proton therapy to patients in the Pacific Northwest is an important milestone in its mission.
“SCCA was formed to accelerate the development and evaluation of new therapies for cancer, and in turn make those therapies more widely available in our region,” said Norm Hubbard, executive vice president of SCCA. “Proton therapy has emerged as a compelling treatment for pediatric and many adult cancer patients, and prior to development of this Center, patients would have to travel hundreds of miles to receive this precise, live-saving treatment.”
Currently available at only nine centers in the United States, proton therapy is an advanced form of radiation treatment and an important alternative to standard X-ray radiation for many types of cancer and some non-cancerous tumors. Proton therapy has been shown to be beneficial in the treatment of a broad range of tumor types including brain, central nervous system, gastrointestinal, head and neck, lung and prostate as well as sarcomas and many pediatric cancers. The precision of proton therapy makes it especially effective for treating children and adults with anatomically complex tumors such as at the base of the skull and tumors along the spinal cord.
To continue reading, visit: http://procure.com/media/pressreleases/financing-closed-first-proton-therapy-center-washington.
CONTACT:
PCI
Sky Opila, 312-558-1770
[email protected]
KEYWORDS: United States North America Washington
INDUSTRY KEYWORDS: Health Hospitals Oncology Radiology Other Health
MEDIA:
| Logo |